The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: What has been changed?

Mycophenolate therapy of SLE membranous nephropathy

“…The OSS is a prospective longitudinal study of SLE patients with 4 or more American College of Rheumatology criteria for SLE [23] and recurrently active SLE (2 or more SLE relapses requiring an increase in therapy in the previous 3 years) or persistently active disease (≥4 months of active SLE despite therapy consisting of at least ≥20 mg prednisone daily). The goal of the OSS is to identify risk factors for SLE flare.…”

Pattern of Hematological Manifestations in Patients with Systemic Lupus Erythematosus Attending in a Tertiary Care Hospita

“…3 The criteria, in 1997, underwent another revision and included advancing knowledge about the association of antiphospholipid (aPL) antibodies with SLE. 4 Although the criteria are widely accepted and used, only a few potential manifestations of SLE are represented. The Systemic Lupus International Collaborating Clinics (SLICC) SLE classification criteria comprise 11 clinical and 6 immunological criteria.…”

Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort

“…On the other hand, Raynaud’s phenomenon has been inconsistently associated with migraine headaches in SLE patients 39,40 ; but we failed to demonstrate an association between headaches and NP-damage. Anemia was also associated with a longer time-to-NP damage; anemia is an indicator of disease activity and a predictor of overall damage accrual 41,42 . Thus, we do not have a plausible explanation for this finding.…”